CHINANEWENERGY(01156.HK): 羅兵鹹永道辭任核數師 繼續停牌
格隆匯7月1日丨CHINANEWENERGY(01156.HK)宣佈,公司收到公司核數師羅兵鹹永道於2021年6月28日發出的辭職信。截至2021年3月31日,公司未能根據《上市規則》第13.49(1)條和第13.49(2)條的規定在截止日期前發佈集團截至2020年12月31日止年度經審核的年度業績公吿。
此外,集團披露業務運營的最新情況。集團是中國乙醇生產系統的主要生產商。集團主要為中國燃料乙醇及酒精飲料行業的乙醇生產系統核心系統提供工程設計、設備製造、安裝調試及後續增值維護等綜合服務。儘管停牌,公司仍照常經營,財務狀況良好。
公司股份繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.